Fig. 6From: Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical resultsa, b mfERG improvement in the WJ-MSC Treatment (Table 1, patient no. 18: left eye). a: before the application, b: 6 months later after the applicationBack to article page